“…After 7 days of culture, EPCs were defined as cells dually positive for 1,1¢-dioctadecyl-3,3,3¢,3¢-tetramethylindo-carbocyanine (DiI)-acetylated low-density lipoprotein (acLDL) uptake (Invitrogen, Carlsbad, CA, USA) and BS-1 lectin binding (Sigma-Aldrich, St. Louis, MO, USA) and endothelial markers were examined by flow cytometry analysis using CD31 (BD Pharmingen, San Digeo, CA, USA), von Willebrand factor (vWF) and kinase-insert domain receptor (KDR) (R&D Systems Inc, Minneapolis, MN, USA) as previously described (Chen et al, 2010). Based on the isolation and cultivation protocol, the adherent mononuclear cells were identified as early EPCs (Chen et al, 2010;Giannotti et al, 2010). Circulating EPCs were evaluated by the number of CD34+ ⁄ KDR+ and KDR+ ⁄ CD133 cells per 100 thousands PBMNCs by flow cytometry analysis (Beckman-Coulter, Fullerton, CA, USA) as previously described (Fadini et al, 2008).…”